Endocrinology, Vol 116, 2663-2668, Copyright © 1985 by Endocrine Society

ARTICLES

Involvement of eicosanoids in release of oxytocin and vasopressin from the neural lobe of the rat pituitary

A Negro-Vilar, GD Snyder, JR Falck, S Manna, N Chacos and J Capdevila

Arachidonic acid (AA) is oxidized via three pathways which result in several series of distinct metabolites. Cyclooxygenase produces prostaglandins (PGs), prostacyclins, and thromboxanes. Lipoxygenase produces hydroperoxy/hydroxyeicosatetraenoic acids (HPETE/HETEs) and leukotrienes. Epoxygenase, a recently uncovered pathway, results in epoxyeicosatrienoic acids (EETs). Based on reverse phase HPLC product analysis, this study establishes that all three pathways of AA metabolism are present in microsomal incubates of the neural lobe of the pituitary gland. Addition of PGE2 to incubated fragments of neural lobes of the rat pituitary stimulates secretion of both arginine vasopressin (AVP) and oxytocin in vitro. Inclusion of 5-HETE and 12- HETE in the incubation medium stimulates marginal release of AVP and oxytocin by 12-HETE only. The magnitude of AVP and oxytocin secretion stimulated by the epoxygenase metabolites 8,9-, 11,12-, and 14,15-EET is equal to that caused by PGE2. Maximal stimulation of secretion (3- to 4-fold) requires an EET concentration 10-15 times greater than that of PGE2. In contrast, 5,6-EET is inactive. These data suggest that oxygenated products of AA play a role in AVP and oxytocin secretion. Although PGs appear to be the dominant arachidonate metabolites involved in the release of AVP and oxytocin, the EETs probably have a contributing role.

This article has been cited by other articles:

				A. Sarkis, O. Ito, T. Mori, M. Kohzuki, S. Ito, J. Verbalis, A. W. Cowley Jr., and R. J. Roman Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus Am J Physiol Renal Physiol, December 1, 2005; 289(6): F1333 - F1340. [Abstract] [Full Text] [PDF]

				G. D. Snyder, U. M. Krishna, J. R. Falck, and A. A. Spector Evidence for a membrane site of action for 14,15-EET on expression of aromatase in vascular smooth muscle Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1936 - H1942. [Abstract] [Full Text] [PDF]

				R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF]

				C. M. Thompson, J. H. Capdevila, and H. W. Strobel Recombinant Cytochrome P450 2D18 Metabolism of Dopamine and Arachidonic Acid J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1120 - 1130. [Abstract] [Full Text]

				K. Nithipatikom, P. F. Pratt, and W. B. Campbell Determination of EETs using microbore liquid chromatography with fluorescence detection Am J Physiol Heart Circ Physiol, August 1, 2000; 279(2): H857 - H862. [Abstract] [Full Text] [PDF]

				K. Tanaka, I. Shibuya, N. Kabashima, Y. Ueta, and H. Yamashita Inhibition of Voltage-Dependent Calcium Channels by Prostaglandin E2 in Rat Melanotrophs Endocrinology, December 1, 1998; 139(12): 4801 - 4810. [Abstract] [Full Text] [PDF]

				W. Kozak, I. Archuleta, K. P. Mayfield, A. Kozak, K. Rudolph, and M. J. Kluger Inhibitors of alternative pathways of arachidonate metabolism differentially affect fever in mice Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1998; 275(4): R1031 - R1040. [Abstract] [Full Text] [PDF]

				D. C. Zeldin, J. Foley, J. E. Boyle, C. R. Moomaw, K. B. Tomer, C. Parker, C. Steenbergen, and S. Wu Predominant Expression of an Arachidonate Epoxygenase in Islets of Langerhans Cells in Human and Rat Pancreas Endocrinology, March 1, 1997; 138(3): 1338 - 1346. [Abstract] [Full Text] [PDF]

				W. Qu, J. A. Bradbury, C.-C. Tsao, R. Maronpot, G. J. Harry, C. E. Parker, L. S. Davis, M. D. Breyer, M. P. Waalkes, J. R. Falck, et al. Cytochrome P450 CYP2J9, a New Mouse Arachidonic Acid omega -1 Hydroxylase Predominantly Expressed in Brain J. Biol. Chem., June 29, 2001; 276(27): 25467 - 25479. [Abstract] [Full Text] [PDF]